Fátima Rodrı́guez-Barrios

The amino acid N136 in HIV-1 reverse transcriptase qualifies as a target for new (NNRTI) drug design

Jan Balzarini, Johan Auwerx, Fátima Rodrı́guez-Barrios, Francesca Ceccherini‐Silberstein, Carlos Garcı́a-Aparicio, Sonsoles Velázquez, De Clercq Erik, Carlo Federico Perno, Marı́a-José Camarasa, Federico Gago (2004). The amino acid N136 in HIV-1 reverse transcriptase qualifies as a target for new (NNRTI) drug design.